Arenberg Michael 4
4 · Imago BioSciences, Inc. · Filed Dec 29, 2022
Insider Transaction Report
Form 4
Arenberg Michael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-12-27$18.44/sh+66,794$1,231,681→ 119,895 total - Exercise/Conversion
Common Stock
2022-12-27$15.45/sh+28,206$435,783→ 53,101 total - Sale
Common Stock
2022-12-27$35.93/sh−70,508$2,533,352→ 49,387 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-27−28,206→ 2,149 totalExercise: $15.45From: 2022-12-15Exp: 2032-11-07→ Common Stock (28,206 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-27−66,794→ 304,206 totalExercise: $18.44From: 2022-12-15Exp: 2032-03-22→ Common Stock (66,794 underlying)
Footnotes (1)
- [F1]The transaction was executed in multiple trades in prices ranging from $35.93 to $35.935, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.